«A team at the Broad Institute, a Harvard - M.I.T. collaborative for genomics research, has devised a way of screening for drugs that attack cancer stem cells but
leave ordinary cells unharmed.
From the NYT: «A team at the Broad Institute, a Harvard - M.I.T. collaborative for genomics research, has devised a way of screening for drugs that attack cancer stem cells but
leave ordinary cells unharmed.